Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,130.00    -4.00 (-0.10%)
Bid:
4,122.00
Ask:
4,130.00
Spread: 8.00 (0.194%)
Market Cap: £4.33b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Pre-Close Trading Update

10 Jul 2008 07:00

RNS Number : 7434Y
Computacenter PLC
10 July 2008
 



Computacenter plc

Pre-Close Trading Update

Computacenter is today holding an Investor and Analyst conference call to provide an update on trading for the six months to 30 June 2008.

Group revenues for the first-half of 2008 will show growth of approximately 8%. Even after taking into consideration the benefit of a strengthening euro, the organic growth rate is the strongest for a number of years. 

Since we last reported on trading, the improved performance at our UK and French subsidiaries has continued. We are pleased to report that the Q2 2008 performance was ahead of Q1 2008, and ahead of Q2 2007 in both revenue and profit in both countries.

As we have already announced, the UK had a difficult start to 2008 and the first six weeks trading was particularly tough, however UK sales for the first six months were up 4.8% and up 8.3% in Q2. We have seen strong growth from our Software Business Unit where we believe we have gained significant market share however this does have a diluting effect on our overall gross margins.

We continue to invest heavily in our UK business to build our position in the mid-market and to increase our services capability. These investments, together with the poor start to the year will, as anticipated, result in UK first-half profitability below last year.

The improved performance in France in Q2 has meant that the first half loss will be broadly similar to H1 2007 in local currency but the positive trend in performance together with some major contract successes bodes well for the second half of 2008.

In Germany trading has been consistent throughout the first half of 2008. Revenue in local currency has fallen slightly in comparison to the first-half of 2007, however, mainly due to improved services margins, the profit growth we experienced last year has continued. 

Group debt at the end of the period will be approx £30M (2007H1: £16.5M) before customer specific financing. Good cash generation meant that before taking into account the £20.8M we have spent buying back shares since 1 July 2007 our net debt position improved by £7.3M.

We are encouraged by the Group's performance in the second quarter. Although there is much uncertainty in the market place, customers undoubtedly need to invest in information technology to increase the efficiency of their businesses, reduce risk and improve their competitiveness. We believe customers are increasingly looking to Computacenter to gain an increased value from their information technology investment.

As anticipated first-half Group pre-tax profits are expected to be lower than the same period last year. However, due to the impact of share buy backs and an improved tax position, earnings per share will show aimprovement.

Computacenter will report its Interim results on 28 August 2008.

Enquiries:

 

Computacenter plc
 
Mike Norris, Chief Executive
01707 631601
Tony Conophy, Finance Director
01707 631515
Tessa Freeman, PR Manager
01707 631514
 
 
Tulchan Communications
020 7353 4200
Andrew Grant
 
Stephen Malthouse
 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFGGGNNLZGRZM
Date   Source Headline
19th Jan 20184:00 pmRNSDirectorate Change
14th Nov 20177:00 amRNSTrading Statement
27th Oct 20177:00 amRNSTrading Statement 3rd Quarter 2017
18th Oct 20173:46 pmRNSDirector/PDMR Shareholding
15th Sep 201711:30 amRNSDirector/PDMR Shareholding
7th Sep 20171:00 pmRNSHolding(s) in Company
25th Aug 20177:00 amRNSHalf-year Report
8th Aug 20172:30 pmRNSBlock listing Interim Review
5th Jul 201711:30 amRNSDirector/PDMR Shareholding
4th Jul 201711:30 amRNSDirector Declaration
21st Jun 20179:00 amRNSDirector Declaration
7th Jun 20171:30 pmRNSDirector/PDMR Shareholding
4th May 201710:00 amRNSResult of AGM
24th Apr 20177:00 amRNSTrading Statement 1st Quarter 2017
6th Apr 20171:30 pmRNSDirector/PDMR Shareholding
30th Mar 20172:45 pmRNSAnnual Report 2016 & Notice of AGM 2017
30th Mar 20177:00 amRNSDirector Declaration
29th Mar 20175:45 pmRNSDirector/PDMR Shareholding
29th Mar 201712:00 pmRNSDirector/PDMR Shareholding
27th Mar 20175:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20174:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20174:00 pmRNSDirector/PDMR Shareholding
13th Mar 20177:00 amRNSFinal Results 2016
8th Feb 201712:00 pmRNSBlock Listing Interim Review
23rd Jan 20177:00 amRNSPre-Close Trading Statement
10th Jan 20176:00 pmRNSDirector/PDMR Shareholding
14th Dec 20164:30 pmRNSDirector/PDMR Shareholding
1st Dec 20161:00 pmRNSDirector/PDMR Shareholding
28th Nov 20164:15 pmRNSDirector/PDMR Shareholding
28th Nov 20164:15 pmRNSDirector/PDMR Shareholding
17th Nov 201612:00 pmRNSDirector/PDMR Shareholding
15th Nov 201610:00 amRNSDirector/PDMR Shareholding
15th Nov 201610:00 amRNSDirector/PDMR Shareholding
11th Nov 20161:00 pmRNSDirector/PDMR Shareholding
11th Nov 20161:00 pmRNSDirector/PDMR Shareholding
11th Nov 20161:00 pmRNSDirector/PDMR Shareholding
11th Nov 201612:00 pmRNSDirectorate Change
10th Nov 201610:00 amRNSDirector/PDMR Shareholding
9th Nov 20166:00 pmRNSDirector/PDMR Shareholding
9th Nov 20166:00 pmRNSDirector/PDMR Shareholding
21st Oct 20167:00 amRNSQ3 2016 Trading Statement
20th Oct 201611:41 amRNSDirector/PDMR Shareholding
19th Oct 20164:30 pmRNSHolding(s) in Company
19th Oct 20164:30 pmRNSHolding(s) in Company
30th Sep 20165:23 pmRNSHolding(s) in Company
14th Sep 20165:59 pmRNSCompany Secretary Change
9th Sep 20163:00 pmRNSHolding(s) in Company
1st Sep 201610:30 amRNSDirector/PDMR Shareholding
26th Aug 20167:00 amRNSHalf-year Report
8th Aug 20162:00 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.